Dang Lin
Overview
Explore the profile of Dang Lin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
346
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Li H, Lin D, Lv T
Transl Lung Cancer Res
. 2022 Sep;
11(8):1727-1730.
PMID: 36090629
No abstract available.
12.
Wang Y, Gu Y, Shen K, Cui X, Min R, Sun S, et al.
BMC Infect Dis
. 2021 Oct;
21(1):1043.
PMID: 34625036
Background: Current guidelines support different management of cryptococcosis between severely immunodeficient and immunocompetent populations. However, few studies have focused on cryptococcosis patients with mild-to-moderate immunodeficiency. We performed this study to...
13.
Association of Mutation With Clinical Benefits of Anti-PD-1 Inhibitors in Non-small Cell Lung Cancer
Zhou L, Huang L, Xu Q, Lv Y, Wang Z, Zhan P, et al.
Front Oncol
. 2021 Apr;
11:596542.
PMID: 33828970
Although anti-PD-1 inhibitors exhibit impressive clinical results in non-small cell lung cancer (NSCLC) cases, a substantial percentage of patients do not respond to this treatment. Moreover, the current recommended biomarkers...
14.
Hu H, Li C, Lv T, Li H, Hu Y, Shen Q, et al.
Ann Transl Med
. 2021 Mar;
9(4):288.
PMID: 33708915
Background: Hemorrhage is the second most common complication of percutaneous transthoracic needle biopsy (PTNB), and at present, there is no effective prevention strategy. Contrast-enhanced computed tomography (CECT) has the advantage...
15.
Zhang T, Wan B, Wang L, Li C, Xu Y, Wang X, et al.
Ann Transl Med
. 2020 May;
8(7):491.
PMID: 32395535
Background: Pleural effusion is a common presentation in clinical practice. About 40% of exudative pleural effusion is unable to be diagnosed through thoracentesis, and closed pleural biopsy (CPB) is needed....
16.
Chen X, Wan B, Xu Y, Song Y, Zhan P, Huang L, et al.
Transl Lung Cancer Res
. 2020 Feb;
8(6):1029-1044.
PMID: 32010580
Background: Although rapid on-site evaluation (ROSE) is gradually becoming an integral part of the modern Interventional Pulmonology, the clinical benefit of ROSE is still a matter of controversy. The objective...
17.
Li C, Li C, Zhi C, Liang W, Wang X, Chen X, et al.
J Transl Med
. 2019 Oct;
17(1):355.
PMID: 31665020
Background: Exosomes are 50-150 nm endocytic vesicles secreted by almost all type of cells that carry bioactive molecules from host. These small vesicles are considered to be novel cross-talk circuits...
18.
Li H, Xu Y, Wan B, Song Y, Zhan P, Hu Y, et al.
Transl Lung Cancer Res
. 2019 Sep;
8(4):429-449.
PMID: 31555517
Background: We conducted a meta-analysis to systematically evaluate the relationship between programmed death-ligand 1 (PD-L1) expression and survival in patients with lung cancer. Methods: The electronic databases PubMed, Embase, Cochrane,...
19.
Xu Y, Wan B, Chen X, Zhan P, Zhao Y, Zhang T, et al.
Transl Lung Cancer Res
. 2019 Sep;
8(4):413-428.
PMID: 31555516
Background: We conducted a meta-analysis to evaluate the efficacy of anti-programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD-L1) monotherapy or immunotherapy combined with chemotherapy and further estimated the...
20.
Cui J, Yin Z, Liu G, Chen X, Gao X, Lu H, et al.
Mol Carcinog
. 2019 Aug;
58(10):1919-1924.
PMID: 31420907
Lung cancer is among the most frequently occurring cancers and the leading cause of cancer-related deaths worldwide. Nonsmall cell lung cancer is accountable for 85% to 90% of all lung...